Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... . The importance of pleiotropic properties of angiotensin receptor blockers (in particular, activation ..."
 
Vol 8, No 2 (2012) TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... Data on angiotensin II receptor blockers, one of the main drug classes used in cardiology ..."
 
Vol 4, No 1 (2008) EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONIST LOSARTAN AND ITS COMBINATION WITH DIURETICS ON MYOCARDIAL MORPHO-FUNCTIONAL CONDITIONS IN HYPERTENSIVE PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY Abstract  similar documents
S. N. Tolpygina, E. V. Oschepkova, L. M. Sergakova, A. N. Rogoza
"... Aim. To compare the effects of long-term therapy with angiotensin-II receptor antagonist losartan ..."
 
Vol 9, No 4 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT Abstract  similar documents
S. Yu. Martsevich
"... ) and angiotensin receptor blockers (ARB) on cardiovascular diseases outcomes are evaluated. Data of the recent meta ..."
 
Vol 5, No 4 (2009) TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS Abstract  similar documents
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky
"... Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow ..."
 
Vol 16, No 2 (2020) Treatment of Patients with COVID-19 and Concomitant Cardiovascular Diseases: Do not Forget About the Principles of Evidence-based Medicine Abstract  similar documents
S. Yu. Martsevich
"... and angiotensin II receptor antagonists (ARA) in patients with COVID-19 is analyzed in the article ..."
 
Vol 10, No 6 (2014) IRBESARTAN IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... (myocardial infarction, stroke, chronic heart and renal failure). Angiotensin receptor blockers are the first ..."
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... and Angiotensin Receptor Blockers in Patients Without Heart Failure» J Am Coll Cardiol 2013;61(2):131-42;   http ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... + diet), group A2 (ACE inhibitor + fluvastatin), group B1 (angiotensin II receptor antagonist (ARA II ..."
 
Vol 11, No 6 (2015) Cardiometabolic properties of telmisartan: new perspectives for use Abstract  similar documents
O. M. Drapkina, E. I. Fomicheva
 
Vol 7, No 4 (2011) SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION Abstract  similar documents
S. V. Nedogoda
"... Peculiarities of the treatment with angiotensin II receptor blocker telmisartan are analyzed ..."
 
Vol 4, No 4 (2008) PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY Abstract  similar documents
S. A. Boytsov, I. P. Kolos
"... Angiotensin II receptor antagonists (ARA) established their position recently duet to new ..."
 
Vol 4, No 5 (2008) INHIBITION OF KIDNEY DISORDERS IN CARDIOVASCULAR DISEASES: THE ROLE OF ANGIOTENSIN II RECEPTOR BLOCKERS Abstract  similar documents
V. V. Fomin
"... and cardiovascular complications are discussed with focus on usage of angiotensin II receptor blockers. ..."
 
Vol 9, No 6 (2013) POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK Abstract  similar documents
Z M. Sizova
"... Current possibilities of AT1 receptor blockers (ARBs), such as candesartan, for optimization ..."
 
Vol 9, No 2 (2013) ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: ISN'T IT TIME TO DRAW A LINE UNDER DISCUSSION ABOUT SUPERIORITY Abstract  similar documents
S. Yu. Martsevich
"... -Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure ..."
 
Vol 6, No 1 (2010) ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya
"... Aim. To evaluate the cardioprotective effects of ACE inhibitor, ramipril and angiotensin II ..."
 
Vol 5, No 3 (2009) FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY Abstract  similar documents
O. G. Zaylobidinov, Yu. N. Ziyaev, N. K. Kamilova, A. S. Khalilov, B. F. Mukhamedova
 
Vol 3, No 2 (2007) CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS Abstract  similar documents
V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina
"... and peripheral hemodynamics and to evaluate how these characteristics are influenced by angiotensin II receptors ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARB) and β-blockers in the outpatient ..."
 
Vol 4, No 3 (2008) ANGIOTENSIN II AND MYOCARDIAL INFARCTION Abstract  similar documents
O. P. Shevchenko, А. О. Shevchenko
"... The role of angiotensin II in pathogenesis of cardiovascular diseases is discussed. Angiotensin II ..."
 
Vol 7, No 4 (2011) COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) Abstract  similar documents
O. V. Dralova, M. L. Maksimov
 
Vol 9, No 2 (2013) PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET Abstract  similar documents
L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova
"... parathyroidectomy. Conclusion. The pleiotropic effects (reduction in BP and atherogenic lipids levels, as well ..."
 
Vol 15, No 3 (2019) Hypertension and Headache: the Effect of Antihypertensive Drugs Abstract  similar documents
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova
"... ; it is known that some angiotensin converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers ..."
 
Vol 13, No 4 (2017) PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY Abstract  similar documents
O. M. Drapkina, D. U. Akasheva
"... with reduced ejection fraction (<40%). Antagonists of mineralocorticoid receptors, along with angiotensin ..."
 
Vol 3, No 5 (2007) EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION Abstract  similar documents
L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov
"... Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy ..."
 
Vol 10, No 3 (2014) RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING Abstract  similar documents
V. S. Pykhtina, I. D. Strazhesko, M. V. Agaltsov, O. N. Tkacheva
"... is paid to the activation of the renin-angiotensin-aldosterone system as a source of chronic inflammation ..."
 
Vol 6, No 3 (2010) THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova
"... Aim. To study the correlation of the renin-angiotensin-aldosterone system (RAAS) activity ..."
 
Vol 7, No 1 (2011) SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, M. V. Golshmid, G. Yu. Zakharova, I. I. Sinitsina
"... A role of angiotensin-converting enzyme (ACE) inhibitors in cardiovascular diseases treatment ..."
 
Vol 8, No 6 (2012) SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES Abstract  similar documents
K. A. Gyamdzhyan, M. L. Maksimov
"... -angiotensin-aldosterone system are discussed. Efficacy and safety of two major cardiovascular drug classes ..."
 
Vol 12, No 3 (2016) GENETIC PREDICTORS OF ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina
"... and angiotensin II receptor antagonists in the prevention of AF is revealed. RAAS blockers are able not only ..."
 
Vol 15, No 6 (2019) Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
"... single-pill combinations is the combination of an angiotensin II receptor blocker and a calcium channel ..."
 
Vol 2, No 4 (2006) FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS Abstract  similar documents
Yu. M. Lopatin
"... inhibitor and antagonist of angiotensin II receptor are discussed. ..."
 
Vol 13, No 4 (2017) CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE Abstract  similar documents
O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva
"... The features of the pharmacokinetics of the angiotensin II receptor blocker telmisartan ..."
 
Vol 5, No 5 (2009) INFLUENCE OF ANTIHYPERTENSIVE DRUGS ON ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. V. Egorkina, V. M. Gorbunov, E. S. Abirova
"... and angiotensin receptor blockers are shown. Results of comparative studies on influence of combined therapy ..."
 
Vol 12, No 2 (2016) PLEIOTROPIC EFFECTS OF VITAMIN D Abstract  similar documents
O. M. Drapkina, R. N. Shepel
"... Review of clinical studies showing the pleiotropic effect of vitamin D with a detailed description ..."
 
Vol 13, No 2 (2017) ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE Abstract  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya
"... The importance of renin-angiotensin-aldosterone system in pathogenesis of different clinical ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... antihypertensive therapy with or without renin-angiotensin-aldosterone system (RAAS) inhibitors. Material ..."
 
Vol 8, No 1 (2012) EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK Abstract  similar documents
I. M. Sokolov, N. A. Zheleznyakova
"... clinical trials. The triple combination of calcium antagonist, angiotensin II receptor blocker and thiazide ..."
 
Vol 8, No 1 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... include the angiotensin II type 2 and type 1 receptor , neutral endopeptidase, aldosterone synthase ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... include the angiotensin II type 2 and type 1 receptor , neutral endopeptidase, aldosterone synthase ..."
 
Vol 11, No 6 (2015) Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? Abstract  similar documents
I. A. Latfullin, L. F. Galiullina, I. Z. Rakhmatullin, V. V. Klochkov, A. V. Aganov
"... A hypothesis that possible pleiotropic features of different statins could be explained ..."
 
Vol 9, No 6 (2013) СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN Abstract  similar documents
I. I. Chukaeva, Ya. G. Spiryakina
"... properties of angiotensin receptor blocker losartan, so it can be used as first-line therapy in patients ..."
 
Vol 10, No 6 (2014) CHANGES IN PREHOSPITAL PHARMACOTHERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN 2005-2014 ACCORDING TO THE LIS REGISTER Abstract  similar documents
S. Y. Martsevich, M. L. Ginzburg, N. P. Kutishenko, A. V. Zagrebelnyy, I. S. Balashov, L. G. Garkina
"... .7% and 16.3%, respectively) and angiotensin receptor blockers (0.6% and 8.8%, respectively) were found ..."
 
Vol 16, No 4 (2020) Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist Abstract  similar documents
M. V. Zhuravleva, E. V. Luchinina, T. V. Shelekhova, S. Yu. Serebrova, S. A. Belkov, A. I. Dmitriev, G. I. Gorodetskaya
"... or angiotensin II receptor blocker) with a calcium antagonist or diuretic. The combination of lisinopril ..."
 
Vol 15, No 5 (2019) Modern Principles of Treatment of Uncontrolled Hypertension Abstract  similar documents
V. I. Podzolkov, A. I Tarzimanova, Z. O. Georgadze
"... – angiotensin-converting enzyme inhibitors or receptor blockers to angiotensin with a calcium antagonist ..."
 
Vol 6, No 6 (2010) ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 2-3 DEGREE WITH FIXED COMBINATION OF ENALAPRIL OR LOSARTAN WITH HYDROCHLOROTHIAZIDE Abstract  similar documents
A. A. Kudryavtsev, A. S. Ryazanov, N. N. Eremenko, S. A. Kireev
"... (enalapril) or angiotensin II receptor antagonist (losartan) with diuretic (hydrochlorothiazide, HCT ..."
 
Vol 12, No 6 (2016) CHRONIC HEART FAILURE: CLINICAL GUIDELINES AND REAL CLINICAL PRACTICE Abstract  similar documents
E. K. Shavarova, L. A. Babaeva, S. S. Padaryan, N. N. Soseliya, O. I. Lukina, A. S. Milto
"... not receive medical treatment before admission. 34% of patients with HFrEF received ACE inhibitors/angiotensin ..."
 
Vol 16, No 5 (2020) The Role of Adherence to Basic Pharmacotherapy of Heart Failure for Prevention of Late Adverse Events in Patients with Coronary Artery Disease and Left Ventricular Dysfunction After Surgical Revascularization of Myocardium Abstract  PDF (Eng)  similar documents
O. A. Yepanchintseva, K. A. Mikhaliev, I. V. Shklianka, O. J. Zharinov, B. M. Todurov
"... system (RAS; 86.3%) blockers (angiotensin-converting enzyme inhibitors or angiotensin-II receptors ..."
 
Vol 16, No 6 (2020) Chronic Kidney Disease: Current State of the Problem Abstract  similar documents
M. M. Batiushin
"... drugs with nephroprotective properties are angiotensin-converting enzyme inhibitors and angiotensin II ..."
 
Vol 10, No 5 (2014) CHOICE OF THE INITIAL TREATMENT FOR MILD TO MODERATE ARTERIAL HYPERTENSION IN MOSCOW PRIMARY PRACTICE Abstract  similar documents
S. V. Gatsura, O. A. Gatsura, A. N. Golosova
"... declined from 44.4% in 2011-12 to 37.2% in 2013-14 (р<0.05). Angiotensin receptor blockers partially ..."
 
Vol 16, No 4 (2020) Evaluating Adherence to Medical Therapy in Patients with Chronic Heart Failure: Design and First Results of the COMPLIANCE Study Abstract  similar documents
S. Yu. Martsevich, E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih
"... (ACEI)/angiotensin receptor blockers (ARB). Beta-blockers (BB) were prescribed to 96.7% of patients ..."
 
Vol 16, No 1 (2020) An Attempt to Accord the Quality of Therapy of Stable Coronary Heart Disease Patients with Current Clinical Guidelines (ALIGN study): Design and the First Results Abstract  similar documents
S. Yu. Martsevich, E. D. Zharkova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, A. V. Zagrebelnyy
"... -converting enzyme inhibitors were taken by 34 patients (47.9%), and angiotensin receptor blockers by 15 (21 ..."
 
Vol 14, No 1 (2018) OUTPATIENT REGISTRY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION (PROFILE-IM): DATA ON PREHOSPITAL THERAPY IN COMPARISON WITH THE LIS-3 REGISTRY Abstract  similar documents
N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov, S. Yu. Martsevich
"... enzyme inhibitors/angiotensin receptor blockers before AMI in patients from PROFILE-MI were prescribed ..."
 
Vol 14, No 3 (2018) CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... angiotensin converting enzyme inhibitors or angiotensin II receptor blockers. The follow-up duration was from ..."
 
Vol 15, No 4 (2019) Antihypertensive Drug Utilization in Two Districts of Northern Cyprus Abstract  PDF (Eng)  similar documents
M. Tamirci, R. Demirdamar
"... .1%), angiotensin receptor blockers (ARBs) (22.1%), calcium channel blockers (20.4%), angiotensin converting enzyme ..."
 
Vol 16, No 5 (2020) Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register Abstract  similar documents
I. S. Skopets, N. N. Vezikova, A. V. Malafeev, A. N. Malygin, V. A. Litvinova
"... -enzyme inhibitors/angiotensin II receptors blockers. A risk assessment of hospital and 6-month mortality ..."
 
Vol 16, No 6 (2020) Adherence to Clinical Quidelines on Preoperative Assessment and Correction of Cardiovascular Risk in Non-cardiac Surgery Abstract  similar documents
M. D. Nigmatkulova, E. B. Kleymenova, L. P. Yashina, V. A. Otdelenov, S. A. Payushchik, O. D. Konova, D. A. Sychev
"... CoA reductase inhibitors and angiotensin-converting-enzyme (ACE) inhibitors/ angiotensin receptor ..."
 
Vol 15, No 1 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength Abstract  similar documents
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova
"... for knowledge of their pleiotropic effects. The article presents the results of studies of the effect ..."
 
Vol 14, No 3 (2018) COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU Abstract  similar documents
S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca
"... ) inhibitors, then diuretics. The shares of calcium channels blockers (CCB) and angiotensin II receptors ..."
 
Vol 10, No 1 (2014) CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN Abstract  similar documents
N. A. Karoli, G. R. Dolishnya, A. P. Rebrov
"... ) treated with angiotensin II receptors blocker, valsartan. Material and methods. Men with HT and COPD (n ..."
 
Vol 14, No 3 (2018) TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk
"... and amlodipine, as the reference drug of angiotensin II receptor blockers and calcium channel blockers ..."
 
Vol 5, No 6 (2009) EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY) Abstract  similar documents
I. A. Velizhanina, L. I. Gapon, E. S. Velizhanina, M. I. Shupina, A. V. Rudakov, T. S. Bondarenko
"... channel blockers, 420 (53,2%) patients – diuretics and 28 (3,5%) patients - angiotensin II receptor ..."
 
Vol 2, No 2 (2006) PECULIARITIES OF ARTERIAL HYPERTENSION DIAGNOSIS AND SECONDARY PREVENTION ACCORDING TO PHYSICIANS INTERVIEWING Abstract  similar documents
N. S. Oganisyan, N. A. Dmitrieva, A. M. Kochetkov, S. Y. Martsevich
"... medicines (antagonists of angiotensin-II receptors, central acting medicines) made about 1% of share. When ..."
 
Vol 3, No 4 (2007) RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION Abstract  similar documents
I. V. Szirov, E. V. Malichenko
"... Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most ..."
 
Vol 14, No 1 (2018) COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
"... .05). The frequency of the prescriptions of angiotensin II receptor blockers, antagonists of mineralocorticoid ..."
 
Vol 13, No 3 (2017) COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, A. V. Zagrebelnyy, M. M. Loukianov, A. N. Vorobyev, E. A. Pravkina, N. O. Myasnikova
"... combinations in both registries were combinations of angiotensin-converting enzyme inhibitors or angiotensin II ..."
 
Vol 15, No 2 (2019) Assessment of the Adequacy of Drug Choice in Patients with Acute Myocardial Infarction According to the PROFILE-IM Registry Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, E. P. Kalaydzhyan, D. P. Sichinava, V. A. Evdakov
"... and angiotensin receptor antagonists (ARA), prescribed after recent AMI, using the materials of the prospective ..."
 
Vol 15, No 5 (2019) Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis Abstract  similar documents
L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok
"... -converting enzyme inhibitors, and calcium channel blockers, angiotensin II receptor blockers ..."
 
Vol 9, No 5 (2013) CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. N. Kushnarenko, A. V. Govorin
"... include ω-3 polyunsaturated fatty acids, angiotensin receptor antagonists should be used ..."
 
Vol 14, No 6 (2018) Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) Abstract  PDF (Eng)  similar documents
L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk
"... was maximal for ACE inhibitors/angiotensin receptor blockers (83.6%), dual antiplatelet therapy (79.9%) and β ..."
 
Vol 15, No 4 (2019) Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
"... with single-pill combinations (SPCs) in majority patients with AH. Combination of the angiotensin II receptor ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... after 24 weeks in the both groups. Conclusion. The revealed lipid-lowering and pleiotropic effects ..."
 
Vol 15, No 4 (2019) Prevalence, Awareness, Treatment and Control of Hypertension in Russian Federation (Data of Observational ESSERF-2 Study) Abstract  PDF (Eng)  similar documents
Yu. A. Balanova, S. A. Shalnova, A. E. Imaeva, А. V. Kapustina, G. A. Muromtseva, S. V. Evstifeeva, V. I. Tarasov, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, S. S. Yakushin, S. A. Boytsov, O. M. Drapkina
"... received by 49.9% of patients, angiotensin II receptor antagonists by 30.9%, beta blockers – 29 ..."
 
Online First Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease Abstract  similar documents
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova
"... /angiotensin II receptor blockers – 87,6%. 82,9% (n=667) of patients were prescribed treatment for SCAD ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... increase up to 14.7% in prescription rate of angiotensin receptor blockers was revealed ..."
 
Vol 12, No 1 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova
"... was 26.1%. We have noted insufficient ACE inhibitors/angiotensin receptor blockers (ARB) and beta ..."
 
Vol 7, No 1 (2011) NEW ANTIPLATELET DRUGS (PART 1) Abstract  similar documents
A. B. Sumarokov
"... of thromboxane and thrombin receptors. Clinical pharmacology of these drugs is different. This requires a doctor ..."
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... NO synthase (eNOS) Glu298Asp gene, the C242T of the NADPH oxidase p22phox subunit and the angiotensin 2 ..."
 
Vol 15, No 2 (2019) Modern Recommendations and Real Clinical Practice: the Results of the SILA Study Abstract  similar documents
O. A. Kislyak, I. I. Chukaeva, V. A. Vygodin
"... (in different regions). Patients received ACE inhibitors in 50-54% of cases, angiotensin receptor blockers ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... .01, respectively). Patients treated with ACE inhibitors or angiotensin receptor blockers (ARB) had lower all-cause ..."
 
Vol 5, No 2 (2009) CARDIOPROTECTIVE AND NEPHROPROTECTIVE EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR RAMIPRIL Abstract  similar documents
D. A. Napalkov, E. N. Golovenko
 
Vol 5, No 3 (2009) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
S. N. Tereshchenko, N. A. Dzhaiani
 
Vol 1, No 1 (2005) EXPERT CONSENSUS DOCUMENT ON ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CARDIOVASCULAR DISEASE Abstract  similar documents
Jose Lopez-Sendon, Karl Swedberg, John McMurray, Juan Tamargo, Aldo P. Maggioni, Henry Dargie, Michal Tendera, Finn Waagstein, Jan Kjekshus, Philippe Lechat, Christian Torp-Pedersen
"... Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... Data of large-scale research that shows comprehensive abilities of an angiotensin converting ..."
 
Vol 11, No 2 (2015) THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS Abstract  similar documents
E. EL. Trisvetova
"... or angiotensin II blockers the good antihypertensive effect with stable BP profile throughout the day ..."
 
Vol 8, No 4 (2012) UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION Abstract  similar documents
E. A. Protasova, N. V. Furman, O. V. Reshet'ko
"... Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 ..."
 
Vol 16, No 5 (2020) Comparative Characteristics of Patients with Cerebral Stroke and Myocardial Infarction in Outpatient Practice: Structure of Comorbidity, Risk Factors, Drug Treatment and Outcomes Abstract  similar documents
A. N. Vorobyev, K. G. Pereverzeva, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, E. Yu. Okshina, O. M. Drapkina
"... antihypertensive therapy for hypertension, as well as angiotensin-converting-enzyme (ACE) inhibitors/angiotensin ..."
 
Vol 6, No 5 (2010) THE USE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AFTER MYOCARDIAL INFARCTION. WHAT DO EVIDENCE-BASED MEDICINE DATA SPEAK FOR? Abstract  similar documents
S. Yu. Martsevich
"... The main trails proven angiotensin converting enzyme (ACE) inhibitor effects on the life prognosis ..."
 
Vol 3, No 3 (2007) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE? Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... Data of studies devoted to application of angiotensin converting enzyme (ACE) inhibitors in acute ..."
 
Vol 11, No 2 (2015) A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE Abstract  similar documents
B. B. Gegenava, O. M. Drapkina
"... of the selective antagonist of mineralocorticoid receptor eplerenone are analyzed. The advantages of eplerenone ..."
 
Vol 13, No 6 (2017) FEATURES OF MANAGEMENT OF PATIENTS WITH HYPERTENSION IN COMBINATION WITH ISCHEMIC HEART DISEASE: MODERN APPROACHES Abstract  similar documents
D. А. Napalkov, A. A. Sokolova
"... studies allows one to more reliably talk about the pleiotropic effects of amlodipine and to determine its ..."
 
Vol 16, No 2 (2020) LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period Abstract  similar documents
S. Yu. Martsevich, A. V. Zagrebelnyy, N. P. Zolotareva, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, D. A. Startsev, S. V. Blagodatskikh
"... of use of acetylsalicylic acid, clopidogrel, statins, beta-blockers, ACE inhibitors, angiotensin II ..."
 
Vol 14, No 4 (2018) New Clinical Aspects of Eplerenone Use in Clinical Practice Abstract  similar documents
S. R. Gilyarevskiy, N. G. Bendeliani, M. V. Golshmid, I. M. Kuzmina
"... of mineralocorticoid receptor antagonists in patients with heart failure with reduced left ventricular ejection ..."
 
Vol 16, No 6 (2020) Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
"... /angiotensin receptor blockers (ARBs), betablockers, statins. The number of cases of stroke and MI ..."
 
Vol 8, No 2 (2012) IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES? Abstract  similar documents
D. V. Nebieridze, T. V. Kamyshova
"... The role of selective I1 imidazoline receptor agonists and moxonidine in particular , in modern ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... retention, and the activation of renin-angiotensin-aldosterone and sympathoadrenal systems. Carvedilol ..."
 
Vol 6, No 4 (2010) LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... of "cardiovascular continuum". Changes in neurohumoral factors especially activation of the renin-angiotensin ..."
 
Vol 14, No 2 (2018) THE ANALYSIS OF DIFFERENCES IN DOCTORS PREFERENCES IN THE PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN FOUR REGIONS OF THE FAR EASTERN FEDERAL DISTRICT Abstract  similar documents
M. S. Soboleva, Е. E. Loskutova
"... .8%) and bisoprolol (from 2.4% to 20.3%); in group of angiotensin converting enzyme inhibitors – enalapril (from 3 ..."
 
Vol 7, No 5 (2011) NEW ANTIPLATELET DRUGS. PART 2 Abstract  similar documents
A. B. Sumarokov
"... are on their way to clinical application — prasugrel, ticagrelor , elinogrel, thromboxane receptor inhibitors ..."
 
Vol 8, No 5 (2012) TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE Abstract  similar documents
M. M. Rogova, N. A. Mironova, E. S. Rodionova, T. A. Malkina, K. A. Zykov, Zh. D. Bespalova, R. Sh. Bibilashvili, E. E. Efremov, S. P. Golitsyn
"... -cholinergic receptors, and to evaluate their possible contribution to the development and maintenance ..."
 
1 - 100 of 187 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)